Obesity in Focus: ADA Reveals R&D Priorities for Blockbusters-in-Waiting
New data and analyses presented at the American Diabetes Association’s annual meeting highlight the priorities for the next generation of weight loss medicines: muscle preservation, limited side effects and novel targets.
Obesity in Focus: ADA Reveals R&D Priorities for Blockbusters-in-Waiting Read More »
